BIOGEN IDEC LIMITED

1. BIOGEN IDEC LIMITED 2003-11-27 → present
2. BIOGEN LIMITED 1980-12-31 → 2003-11-27
3. BOOHAT TWENTY-FIVE LIMITED 1980-05-19 → 1980-12-31

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 102

Reporting scope

Standalone (parent only)

Auditor

PricewaterhouseCoopers LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“After reviewing the forecasts and projections which considers reasonably possible changes in trading performance and economic conditions, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for at least 12 months from the date of approval of these financial statements. The company meets its day-to-day working capital requirements through funds generated from operations and by being a member of the group's wider cash pooling to maximise control and liquidity. The directors therefore continue to adopt the going concern basis in preparing the financial statements.”

Significant events

• “Effective January 1, 2025, commercialization rights to FAMPYRA has been transitioned to Merz Therapeutics.”
• “In 2023, Convergence Pharmaceuticals Limited, a subsidiary of Biogen International GmbH initiated closure of its bank account and subsequently transferred the remaining funds to the company because of legal entity rationalisation and this has been recorded as Other Income.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

4

last 12 months

Capital events

0

last 24 months

Officers appointed

1

last 12 months

Officers resigned

1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

• Turnover

  -11.6%

  £281,833,000 → £249,012,000

• Cash

  +36.4%

  £57,292,000 → £78,144,000

• Net assets

  +7.4%

  £135,075,000 → £145,084,000

• Employees

  -16.6%

  271 → 226

• Operating profit

  -43.8%

  £21,842,000 → £12,283,000

• Profit before tax

  -37.9%

  £23,959,000 → £14,876,000

• Wages

  -1.9%

  £32,403,000 → £31,792,000

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers